The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

May 7 (Reuters) - Diagnostics firm Bio Rad Laboratories (BIO.N), opens new tab reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and ...

Bio-Rad Laboratories (BIO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Oct 30 (Reuters) - Diagnostics firm Bio-Rad Laboratories (BIO.N), opens new tab posted third-quarter profit above Wall Street estimates on Wednesday, helped by a recovery in demand for analytical ...

Source: Bio-Rad Laboratories, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bio-Rad is an established Fortune 1000 biotech company that creates products that help people live longer, healthier lives. Bio-Rad’s Digital Biology Group (DBG) in Pleasanton makes products ...

Ladies and gentlemen, thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to Bio-Rad's First Quarter 2026 Results ...

Good afternoon. Welcome to the Wells Fargo Healthcare Conference. Thanks for being here. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm. It's a real ...

Bio-Rad Laboratories, Inc. (NYSE:BIO) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 12, Bio-Rad Laboratories, Inc. (NYSE:BIO) delivered solid fourth-quarter ...